The trademark EPIFLEX was filed by VYGON, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on April 19, 2022, and received one opposition filed on June 1, 2022 by MUSCULOSKELETAL TRANSPLANT FOUNDATION on Likelihood of confusion. the opponent was represented by RAUE PARTNERSCHAFT VON RECHTSANWÄLTEN UND RECHTSANWÄLTINNEN MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued June 1, 2022
The application was filed in French, and French was also language of all opposition proceedings (English was selected as the second language).